Literature DB >> 8505588

Decreased serum cholesterol level after snake bite (Vipera palaestinae) as a marker of severity of envenomation.

E Winkler1, M Chovers, S Almog, S Pri-Chen, M Rotenberg, M Tirosh, D Ezra, H Halkin.   

Abstract

In 44 patients bitten by snakes (Vipera palaestinae), admission serum cholesterol levels were negatively correlated with severity of envenomation (mean +/- SD, 175 +/- 49, 137 +/- 36, and 96 +/- 40 mg/dl, respectively, in cases with mild, moderate, and severe clinical manifestations [p < 0.0001]). Concomitant decreases in serum albumin were not significant. These findings were supported by experimental results in rabbits, in which low, medium, and high doses of purified V. palaestinae venom (all in the non-lethal range), led to dose-dependent decreases in serum cholesterol, at 180 minutes, of 9.5% +/- 8.9%, 18.6% +/- 10.1%, and 32.7% +/- 11.8%, respectively (p < 0.01). This rapid decrease in serum cholesterol level is only partially explained by transcapillary lipoprotein leakage and probably indicates changes in lipoprotein transport and metabolism caused by the phospholipase A2 component of V. palaestinae venom. Admission total serum cholesterol level may serve as an indicator of severity of envenomation in patients bitten by snakes of the Vipera genus before full development of the clinical syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505588

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

1.  Evolutionary origin and sequence signatures of the heterodimeric ABCG5/ABCG8 transporter.

Authors:  Jimin Pei; Qian Cong
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.725

2.  Proteomic analysis reveals rattlesnake venom modulation of proteins associated with cardiac tissue damage in mouse hearts.

Authors:  W S Santos; Fabio Montoni; R A S Eichler; Stephanie Santos Suehiro Arcos; Diana Zukas Andreotti; Carolina Yukiko Kisaki; Kimberly Borges Evangelista; Hamida Macêdo Calacina; Ismael Feitosa Lima; Magna Aparecida Maltauro Soares; Eric Conrad Kyle Gren; Valdemir Melechco Carvalho; Emer Suavinho Ferro; Milton Yutaka Nishiyama-Jr; Zhibin Chen; Leo Kei Iwai
Journal:  J Proteomics       Date:  2022-02-17       Impact factor: 3.855

Review 3.  Pharmacological aspects of Vipera xantina palestinae venom.

Authors:  Tatjana Momic; Franziska T Arlinghaus; Hadar Arien-Zakay; Jeoshua Katzhendler; Johannes A Eble; Cezary Marcinkiewicz; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2011-11-14       Impact factor: 4.546

4.  Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study.

Authors:  Yong Jun Jeon; Jong Wan Kim; SungGil Park; Dong Woo Shin
Journal:  Acute Crit Care       Date:  2019-11-18

5.  Coagulopathy in patients who experience snakebite.

Authors:  Jae Seok Kim; Jae Won Yang; Min Soo Kim; Seung Tae Han; Bi Ro Kim; Myung Sang Shin; Jong In Lee; Byoung Geun Han; Seung Ok Choi
Journal:  Korean J Intern Med       Date:  2008-06       Impact factor: 2.884

6.  Snakebites in Lebanon: A Descriptive Study of Snakebite Victims Treated at a Tertiary Care Center in Beirut, Lebanon.

Authors:  Tharwat El Zahran; Ziad Kazzi; Ahel Al-Hajj Chehadeh; Riyad Sadek; Mazen J El Sayed
Journal:  J Emerg Trauma Shock       Date:  2018 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.